Budgeting
Revenue growth remained a hurdle due to hospitals' ongoing reimbursement challenges, but overall stability has increased.
Changes to Medicare's post-hospital payment structure, to bring it closer to that used by private insurers, might save money, Health Affairs says.
Following two years of falling margins, the trend has reversed course, with median margins improving more than 10% over 2018.
From 1980 through 2018, the FDA approved a total of 126 cancer drugs to treat solid and hematologic tumors.
These improvements don't necessarily translate to sufficient margins, however, as hospitals in many markets are still struggling.
The workers are protesting what they see as the healthcare giant's unfair labor practices.
Physician compensation rebounded from a stagnant 2017, but the increase in productivity was negligible.
Pharmaceutical costs are already a large share of most health organizations' budgets and this year's inflation rate may increase drug budgets.
Countries that spent more on social services tended to spend more on healthcare, even after adjusting for poverty and unemployment rates.
The state's general acute-care hospitals spent less than half on low-income patients in 2017 than they did in 2013, data showed.